Definitive Healthcare Corp. (DH)
- Previous Close
6.73 - Open
6.77 - Bid 6.97 x 400
- Ask 7.01 x 300
- Day's Range
6.77 - 6.99 - 52 Week Range
5.53 - 12.45 - Volume
417,618 - Avg. Volume
527,241 - Market Cap (intraday)
823.345M - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
-- - EPS (TTM)
-1.79 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.40
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.
www.definitivehc.com950
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DH
Performance Overview: DH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DH
Valuation Measures
Market Cap
823.35M
Enterprise Value
783.21M
Trailing P/E
--
Forward P/E
18.38
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.14
Price/Book (mrq)
0.96
Enterprise Value/Revenue
3.12
Enterprise Value/EBITDA
-3.25
Financial Highlights
Profitability and Income Statement
Profit Margin
-80.50%
Return on Assets (ttm)
-0.98%
Return on Equity (ttm)
-21.60%
Revenue (ttm)
251.42M
Net Income Avi to Common (ttm)
-202.39M
Diluted EPS (ttm)
-1.79
Balance Sheet and Cash Flow
Total Cash (mrq)
311.49M
Total Debt/Equity (mrq)
22.34%
Levered Free Cash Flow (ttm)
102.28M